secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0001493152-23-008364
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pure Bioscience names Robert Bartlett CEO; Tom Lee resigns, stays on Board
--------------------------------------------------------------------------

- Tom Y. Lee resigned as President and CEO effective March 15, 2023; will continue on Board.
- Robert Bartlett, Board member since Feb 2023, appointed President and CEO; base salary $300k, sign-on $17.5k.
- Bartlett granted option to purchase 500k shares, vesting quarterly over one year.
- Tom Myers transitioned from COO to EVP Technology and Development; remains on Board.
- Kristin A. Taylor resigned from Board effective March 19, 2023; no disagreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer